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Objective: To demonstrate the feasibility and safety of using functional magnetic resonance imaging (fMRI) to determine
the blood oxygen level dependent changes (BOLD) in patients undergoing vagal nerve stimulation (VNS) for the treatment
of epilepsy.
Methods: Four patients with an implanted vagus nerve stimulator had fMRI images acquired during several cycles of inter-
mittent VNS. Blood oxygen level dependent changes were detected. These regions were then superimposed upon the patients’
structural MR images.
Results: Patients undergoing VNS tolerated fMRI without difficulty. No complications with the implanted stimulators were en-
countered. Areas of activation were noted in several cortical regions, including frontal, temporal, parietal, and occipital cortices.
Conclusion: Our study in four patients shows fMRI can be performed safely in patients with an implanted vagal nerve stimulator.
The successful use of fMRI during VNS offers potential advantages over PET imaging by allowing rapid image acquisition and
the ability to repeatedly study patients over time. Our preliminary results differ from previous PET or SPECT studies in failing
to detect changes in subcortical areas. This finding could be due to the smaller n in this study compared with the other studies.
c© 2002 BEA Trading Ltd. Published by Elsevier Science Ltd. All rights reserved
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INTRODUCTION
Vagal nerve stimulation (VNS) is the first FDA
approved device to treat medically refractory patients
with partial onset seizures. Seizure frequency can be
reduced by an average of 30 to 40%1. The details of
how VNS can reduce seizure frequency is unknown.
Attempts at functional imaging have consisted of
cerebral blood flow studies (PET and SPECT) that
have been performed in a small number of patients
with VNS2–8.
Functional magnetic resonance imaging (fMRI)
is a noninvasive technique to map various brain
functions. Images are a result of detecting local
changes in cerebral blood oxygenation presumably as
a consequence of neuronal activity. Image acquisition
is of the order of milliseconds9–12.
To date, fMRI has not been reportedly utilized to
study the effect of VNS upon the central nervous
system. This pilot study represents an initial attempt
to study the acquisition of fMRI images during
intermittent VNS in patients with partial seizures.
METHODS
Four human subjects (named A, B, C, D) with
intractable partial seizures and a 6 months history
of implanted vagus nerve stimulator (Cyberonicsr
model 100) were asked to give written informed
consent to undergo fMRI imaging. The subjects were
instructed to remain in a relaxed, motionless resting
state10, 11 for the duration of image acquisition. For
each subject, anatomic images were acquired. This
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was followed by three time-courses of gradient-
recalled echo-planar images (EPI). Our priority in this
pilot study was to select patients who could provide a
high level of cooperation to assure acceptable results.
As a result the four subjects were not demographically
matched. The patients were considered refractory to
medication and had received long term monitoring as
part of their presurgical evaluation, but found to have
poorly localized seizures. Table 1 depicts the essential
patient characteristics.
Table 1: Patient Characteristics.
SZ Time of post-
Patient/ Age Seizure duration Etiology implant fMRI
gender (years) type(s) (years) (months)
A/M 22 SPS/CPS 22 None 6
B/M 49 SPS 2 Brain 6
abscess
C/M 27 CPS 26.5 None 7
D/F 28 GTC 27.5 None 6
GTC, generalized tonic–clonic; CPS, complex partial seizure;
S, simple; M, male; F, female.
Patient A was a 22-year old man who suffered
daily simple partial seizure as well as complex partial
seizures twice per week. He was scanned 6 months
±2 weeks post-implant. He was on extended release
carbamazepine 600 mg bid and 3000 mg QD of
valproic acid in divided dosages. On follow-up at 2
years post-VNS implant (with a setting of 1.8 min off
and 30 seconds on at 2 mA) he no longer suffered from
simple seizures but still had weekly complex partial
events and oxcarbazepine was added.
Patient B was a 49-year old man who prior to
implant suffered 3–4 simple seizures per day and was
scanned 6 months ±2 weeks post-implant. He was
taking 900 mg daily of carbamazepine and 550 mg
of topiramate daily. 21 months post-implant (setting
of 5 minutes off and 30 seconds on at 2.0 mA) the
patient has had only rare seizures on a reduced amount
of medication. The reduction of dosage did not affect
seizure frequency.
Patient C was a 27-year old man who suffered 6–7
complex partial seizures per month and was scanned
7 months post-implant. He was taking divided doses
of 1200 mg QD carbamazepine, 750 mg daily of
valproic acid, 625 mg daily of mysoline and 600 mg
daily of topiramate. At 18 month post-implant (setting
of 5 minutes off and 30 seconds on at 2.25 mA)
he suffered one seizure per week but the number of
medications was reduced to one (valproic acid).
Patient D was a 28 year old woman who suffered
one secondarily generalized tonic–clonic seizure per
week and was scanned 6 months ±2 weeks post-
implant. She was on lamotrigine 250 mg daily and
topiramate 50 mg daily. At one-year follow-up (setting
of 5 minutes off and 30 seconds on at 1.5 mA)
the patient felt no change in seizure frequency and
eventually requested the device to be turned off.
Fig. 1(a): Schematic of the position and orientation of the
VNS device. The device must be oriented in this fashion to
prevent the static magnetic field from influencing the reed
switch.
All devices were set at a frequency of 30 Hz and
pulse width of 500 microseconds. The device that had
been implanted was oriented as shown in Fig. 1(a). In
this way, the static magnetic field Bo has no significant
effect on the reed switch in the device while the
patient is in the scanner. This is because the reed
switch is now oriented parallel to the static magnetic
field, the direction of which is shown in Fig. 1(a).
Although positioning the device exactly as shown in
our figure assures precise parallel orientation of the
reed switch, it has been demonstrated13 that provided
that the device is oriented so that the electrode inputs
are parallel to the long axis of the patient, the device
should operate during MRI scanning. This suggests
that exact parallel orientation of the reed switch is
not imperative. Hence, any slight pendular shifting of
the device about the sutured down contact may not
affect fMRI-scanning ability. Moreover, verification of
positioning can be done via chest x-ray prior to fMRI
scanning if necessary. However, this orientation of the
device will not prevent stimulation being inhibited
while the patient is near the scanner. The suggested
orientation, unlike any other positioning, only assures
that once the patient is actually in the scanner, parallel
to the magnetic field, the device will resume cycling.
This can be verified once the patient reports feeling the
device cycle on and off. Verification that the device
was operating during scanning can also be done by
checking the device history. First note the total ‘on’
time before scanning and then after scanning. Then
subtract the times and compare with the duration the
patient was in the scanner as well as when the patient
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reported the ‘on’ cycle. We evaluated the model 100
and not the newer model 101. The reed switch on
model 101 is located differently in the device. See
Fig. 1(b). However, in this case, if the device is
oriented as Maniker13 suggests for model 100, with
the input leads oriented parallel to the long axis of the
patient, the switch is exactly parallel.
Reed
Switch
Model 100 Model 101
Reed
Switch
Fig. 1(b): Schematics showing the orientation of the reed
switch in model 100 and model 101. (Cyberonicsr company
information.)
Only the head coil was used and this avoided the
possibility of wire heating in the implanted device that
can occur with a body transmit coil14. IRB approval
was obtained because the output current was not
programmed to 0 mA when the patient was being
scanned, as recommended in the physician manual15.
During the scan the programmed stimulation was
0.25 mA less than that usually programmed for each
patient. The reason for choosing this setting was
mainly for tolerance purposes. Despite the lowering
of their settings, patients were still reporting feeling
the stimulation.
The imaging platform was a 1.5 T clinical imager
(Sigma, General Electric Medical Systems, Waukesha,
WI) specially equipped with a home-built balanced
torque, three-axis gradient coil, and shielded end-
capped quadrature transmit/receive coil16–18. High-
resolution anatomic images were obtained in sagittal
projections with the spoiled GRASS pulse sequence,
with TR = 600 ms, TE = 10 ms, FOV = 24 cm,
and matrix size = 256 × 256. On the basis of these
images, 12 slices covering the entire brain were used
for functional imaging. For each resting acquisition,
a time course of images, consisting of 30 seconds
‘on’ and 30 seconds ‘off’ for 6 minutes, was obtained
with gradient-recalled EPI: 40 ms. TE, 24 cm FOV,
64 × 64 matrix, and 8 mm slice thickness. Since the
patients could feel stimulation commence and report
it, the cycling of the device could be determined. Other
imaging parameters consisted of TR = 2000 ms (flip
angle [FA] = 87◦). The signal intensity was plotted
as a function of time for each pixel, resulting in
64 × 64 matrix/8 mm cut thickness yielding voxels
with dimensions of 3.75 × 3.75 × 8 mm. During
reconstruction of images, Bo field maps were used to
reduce field inhomogenieties.
All data were analyzed for the presence of motion-
induced artifacts. While many algorithms exist for the
detection and correction of misregistered images, a
contour-based cross-correlation algorithm was used
for detecting the presence of head motion19, 20. A
contour image of the first image in each data set was
used as a reference and the motion estimated for every
other image in the data set. The estimated motion was
tabulated as a function of time for each subject and
for each data set. Data sets that exhibited head motion
were corrected prior to further analysis. After motion
correction, if an image set still exhibited head motion
of more than one pixel, the image set was discarded.
A representative time-course from each subject was
used as a reference waveform and cross-correlated
with every pixel in the image on a pixel-by-pixel
basis. Cross-correlation assumes that neuronal activity
and the fMRI signal change coherently with the
stimulus paradigm. For the paradigm used in this
study, this assumption seems reasonable. Using an
ideal reference waveform, cross-correlation analysis
identifies pixels that have a shape that is similar to the
reference waveform. Only pixels with a correlation-
coefficient greater than 0.35 were considered as
this assured a statistical significance of P< 0.01.
Moreover, selection of this correlation-coefficient
threshold yields the given p value and represents the
statistical significance for acceptance of signals not
due to chance21, 22.
RESULTS
During the stimulation phase, signal intensity from
different regions of the brain varied by about 5%
above the baseline. During the no-stimulation phase
acquisitions, the signal intensity varied by about 1%
of baseline. By inspection, it was seen in a number
of pixels that signal intensity changed synchronously
with the on:off cycle of the VNS. Fourier analysis
performed on time-course plots indicated a dominant
low-frequency component present on these pixels. It
has been demonstrated that the VNS ‘on’ state does
not distort or interfere with images23. Similarly, we
did not find this to be the case with our imaging results.
Tables 2 and 3 show the tally of activated
pixels per region and side of each patient. It also
shows tabulated totals by region for all patients.
The images shown in Fig. 2 are selected images
representatives of the 12 sagittal slices obtained
for each patient. Pixels in yellow, orange, and red
indicated the most significant change. Moreover at
our institution (MCW) the yellow, orange, and red
pixels were set to signify a correlation greater than
0.55 (P< 0.001), 0.45 (P< 0.005) and 0.35 (P< 0.01)
respectively. However, color-coding can be adjusted
according to preference22.
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Tables 2 and 3: Tabulated number of pixels activated in
various brain areas by patient, A–D. Pixels that were red,
orange or yellow were manually counted.
Table 2: Left hemisphere
Brain region A B C D Total
Superior 51 11 9 12 83
temporal
Temporal pole 5 2 3 1 11
Supra marginal 10 7 5 5 27
Inferior frontal 30 7 21 31 89
Supplementary 100 31 17 25 173
motor
Pre-motor 11 17 14 42
Post mid frontal 30 9 5 40 84
Anterior cingulate 5 11 1 17
Posterior cingulate 1 3 1 5
Thalamus 5 4 2 11
Angular 1 4 6 11
Medial parietal 3 2 17 22
Mid temp 11 22 33
Medial occ 13 11 1 25
Anterior frontal 26 5 57 88
Totals 721
Table 3: Right hemisphere
Brain region A B C D Total
Superior 2 13 15
temporal
Temporal pole 23 13 36
Supra marginal 23 4 27
Inferior frontal 57 3 9 19 79
Supplementary 30 18 35 7 90
motor
Pre-motor 3 3 6
Post mid 28 19 17 23 87
Frontal
Anterior 15 1 1 17
Cingulate
Posterior 8 4 12
Cingulate
Thalamus 4 3 7 14
Angular 2 7 9
Medial parietal 3 29 32
Mid temp 2 2
Medial occ 20 10 28 6 64
Anterior frontal 75 14 1 23 113
Occipital 22 3 4 29
Totals 632
Overall, there were four subregions of brain
showing consistent and robust activation in each
of the individuals studied. These include the left
superior temporal gyrus, the inferior frontal gyrus
bilaterally, medial portions of the superior frontal
gyrus bilaterally in the region of supplementary motor
cortex, and the posterior aspect of the middle frontal
gyrus bilaterally. The other areas showed variable and
less robust activity.
DISCUSSION
fMRI identified areas of blood flow alteration with
left vagus nerve stimulation in refractory partial onset
seizure patients. These changes were predominantly
seen in bi-frontal and parietal structures. This is
not surprising given the known widespread anatomic
pathways of the vagus nerve.
The results show obvious variation between sub-
jects. No correlation was found between the activated
regions, stimulation parameters and seizure frequency
reduction. We however, did not expect this due to the
small sample size. On the other hand, our method of
data analysis did not allow for detection of the possible
decreased areas of neuronal activation.
The widespread and variable activation seen in
our four subjects may be influenced by a variety
of factors, including statistical variance associated
with a small study population, uncontrolled cognitive
processes, and uncontrolled responses to vagal nerve
stimulation. The response of the subjects to the
perception generated by vagal nerve stimulation and
inherent variability of the responses among subjects is
unknown, but may have accounted for the variability
in activation seen within specific subregions of brain.
For example, subject A showed much greater activity
in the left superior temporal and supplementary motor
areas, than the other three subjects. Whether this is
simply due to statistical variance or is a genuine
response to vagal nerve stimulation is not clear at this
point. On the other hand, the robust and consistent
activation of certain subregions of brain is of unknown
significance. Future studies are required to confirm
the predominant activity seen and help understand the
significance of this finding.
It is difficult to make fruitful comparisons between
our fMRI results and those seen with PET or
SPECT studies. The methods and patients differed
considerably among all these studies. Garnett et al.
2 found regional cerebral blood flow changes (rCBF)
in the left anterior cingulate gyrus among the five
patients they studied. However, two of the patients
had ‘electrical evidence of seizure activity’ during
the study. Details of the stimulation parameters and
duration of implant were not mentioned. Ko et al.3
found increased rCBF in the contralateral thalamus,
posterior temporal cortex, left putamen and inferior
cerebellum in three patients they studied. Two of the
patients had epilepsy surgery prior to VNS implant.
The three patients had at least 2 months of VNS
prior to being scanned. A second study by Ko4 with
nine patients found a correlation with reduction in
seizure frequency and decreased rCBF in the right
fusiform gyrus. Henry et al.5 studied 10 patients
within 24 hours of VNS implant. As such, the intensity
of stimulation in their ‘high-stimulation’ group was
considerably lower than that seen with patients who
have had VNS for a longer duration. Nevertheless,
they found significant changes in rCBF in dorsal
medulla, right sensory cortex, bilateral thalamus,
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Patient A
Patient B
Patient C
Patient D
Fig. 2: Selected images of each patient indicating areas of significant change in activity. Each patient appeared to demonstrate
more robust signal in the frontal and parietal lobes (sensory and motor strips). Patient D had a modest change noted in the
temporal lobes (not shown). The linear signal inferior to temporal lobe of second slice of Patient D is likely the transverse sinus.
Patient C had more motion detected than the others. See text for additional comments.
cerebellum and multiple limbic structures. Henry6, in
a second study using 11 patients, found a correlation
with decreased seizure frequency and rCBF changes
in the thalamus. Vonck et al.7 noted a significant
rCBF change (decrease) in the left thalamus with
stimulation. The changes in rCBF found in these
five studies are consistent with the known anatomic
pathways of the vagus nerve8.
Our study found little activation in the brainstem,
thalamus, and basal ganglia The relative lack of
activity seen in these deeper structures may be due to
the lower concentration of microvasculature causing a
less BOLD signal compared to that seen with cortical
activation. This could also be due to the function of our
scanning and analysis methods. Another more refined
protocol will help explore brainstem involvement.
Moreover, our intention in this pilot study was to
establish safety and feasibility of using fMRI to
evaluate VNS effects. We acknowledge that our results
in general are not ready to stand up to vigorous
comparisons with established PET imaging.
We make the assumption that the changes noted
on fMRI are a result of neuronal activity caused
by VNS. Whether VNS causes any direct micro-
vascular changes apart from neuronal influence is not
clear. Validation of our assumption is expected once
individual patients have both fMRI and either PET or
SPECT scans.
Our patients had seizures that were poorly localized
on prior monitoring. What effects fMRI can detect
in primary generalized epilepsy patients with VNS
remain to be seen. A study with a larger number
of patients may be able to demonstrate differences
between patients that have had varying success
with their device. Additional studies may also allow
comparison of different stimulator settings. Possibly,
manual stimulation of the left side of the neck could
be compared with VNS. This might help clarify if the
changes seen are a result of local sensory stimulation
or due to vagus nerve pathway stimulation.
No complications of VNS were noted in any of
the four patients studied. The patients denied any
discomfort during the study. After scanning, the
devices were re-interrogated. The study parameter
settings were unaltered; verifying that scanning did
not change the programmed parameters. The patient’s
162 R. Sucholeiki et al.
prior setting were reprogrammed and on follow-up
visits the patients denied any complaints. Our study
in four patients shows fMRI can be performed safely
in patients with implanted vagal nerve stimulators.
REFERENCES
1. Morris III, G. L. and Mueller, W. M. The Vagus Nerve
Stimulation Study Group EO1-EO5. Long-term treatment with
vagus nerve stimulation in patients with refractory epilepsy.
Neurology 1999; 53: 1731–1735.
2. Garnett, E. S., Nahmias, C., Scheffel, A. et al. Regional
cerebral blood flow in man manipulated by direct vagal nerve
stimulation. Pacing and Clinical Electrophysiology 1992; 15:
1579–1580.
3. Ko, D., Heck, C., Grafton, S. et al. Vagus nerve stimulation
activates central nervous system structures in epileptic patients
during PET H152 O blood flow imaging. Neurosurgery 1996;
39: 426–431.
4. Ko, D., Grafton, S., Gott, P. et al. PET 15O Cerebral blood
flow study of vagus nerve stimulation: progressive changes
over time and correlation with efficacy. Epilepsia 1998; 39
(Suppl. 6): 101.
5. Henry, T. R., Bakay, R. A. E., Votaw, J. R. et al. Acute vagus
nerve stimulation selectively alters blood flow in somatosen-
sory and limbic cortex and the cerebellum of patients with
complex partial seizures. Epilepsia 1997; 38 (Suppl. 8): 144.
6. Henry, T. R., Votaw, J. R., Pennel, P. B. et al. Acute blood
flow changes and efficacy of vagus nerve stimulation in partial
epilepsy. Neurology 1999; 52: 1166–1173.
7. Vonck, K., Boon, P., Van Laere, K. et al. Acute single
photon emission computed tomographic study of vagus
nerve stimulation in refractory epilepsy. Epilepsia 2000; 41:
601–609.
8. Henry, T. R. PET: cerebral blood flow and glucose
metabolism-presurgical localization. Advances in Neurology
2000; 83: 105–200.
9. DeYoe, D. A., Bandettini, P. A., Neitz, J., Miller, D. and
Winans, P. Functional magnetic resonance imaging (FMRI) of
the human brain. Journal of Neuroscience Methods 1994; 54:
171–187.
10. Bandettini, P. A., Wong, E. C., Hincks, R. S., Tikof-
sky, R. S. and Hyde, J. S. Time course EPI of human
brain function during task activation. Magnetic Resonance in
Medicine 1992; 25: 390–397.
11. Frahm, J., Bruhn, H., Merboldt, K. and Hanicke, W. Dynamic
MRI of human brain oxygenation during rest and photic
stimulation. Journal of Magnetic Resonance Imaging 1992; 2:
501–505.
12. Kwong, K. K., Belliveau, J. W., Chesler, D. A. et al. Dynamic
resonance imaging of human brain activity during primary
sensory stimulation. Proceedings of the National Academy of
Science United States of America 1992; 89: 5675–5679.
13. Maniker, A., Wen-Ching, L., Marks, D., Moser, K. and
Kalnin, A. Positioning of vagal nerve stimulators: technical
note. Surgical Neurology 2000; 53: 178–181.
14. Nyenhuis, J. A., Bourland, J. D., Foster, K. S. et al. Testing
of MRI compatibility of the cyberonics model 100 NCP
generator and model 300 series lead. Epilepsia 1997; 38
(Suppl. 8): (abstract).
15. Cyberonics. Physicians Manual for the Model 100 NCP pulse
Generator. December 1998.
16. Wong, E. C. and Hyde, J. S. The design of surface gradient
coil for MRI. In: Proceedings of the Society for Magnetic
Resonance Medicine, 10th Annual Meeting. New York, 1991:
p. 346.
17. Wong, E. C., Bandettini, P. A. and Hyde, J. S. Echo-planar
imaging of the human brain using a three axis local gradient
coil. Proceedings of the Society for Magnetic Resonance
Medicine 1992; 1: 105.
18. Wong, E. C., Boskamp, E. and Hyde, J. S. A volume optimized
quadrature elliptical endcap birdcage brain coil. Proceedings
of the Society for Magnetic Resonance Medicine 1992; 2:
4015.
19. Connaughton, P. V., Jesmanowics, A., Froncisz, W. and
Hyde, J. S. Two applications of cross-correlation in MRI:
Image registration of CT, PET, and/or MR images of the brain.
In: Proceedings of the 11th ISMRM. Berlin, 1992: p. 4219.
20. Biswal, B. B. and Hyde, J. S. A novel image registration
technique for fMRI. In: Proceedings of the 6th ISMRM.
Sydney, 1998: p. 2132.
21. Hays, W. L. Statistics for the Social Sciences. 1st Edition. New
York, Holt, Rinehart and Winston, 1973.
22. Bandettini, P. A., Jesmanowicz, A., Wong, E. C. and
Hyde, J. S. Processing strategies for time-course data sets
in functional MRI of the human brain. MRM 1993; 30:
161–173.
23. Liu, W. C., Mosier, K., Marks, D., Kalnin, A. J.,
Wang, T. J. and Devereaux, P. Performance evaluation of the
NeuroCybernetic Prosthesis system for fMRI. Proceedings of
International Society for Magnetic Resonance in Medicine.
Abstract November 1998. (Full reference.)
